chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 10 minutes after receiving the vaccine I experienced a tickling sensation, similar to 1st Dose that started from the left arm and going from upper torso to lower extremities both sides Approximately 20 minutes after receiving the vaccine I experienced extremely dry mouth and difficulty in swallowing.  Tongue felt swollen, but I did not require intervention, I took small sips of water which helped with the dry mouth and swallowing.   Approximately 25 minutes after receiving the vaccine I experienced the after taste of the vaccine.  By end of the observation period symptoms/reaction were gone Approximately 3 hours following the 2nd Dose started experiencing a migraine, nausea and chills.
Severe Physical Fatigue/ Mind Fog/Cognitive Impairment, Worsening Bronchial Asthma, Worsening Pain from neck, back, and shoulder injuries diagnosed by Dr., loss of sleep and worsening mood disorder from chronic pain. Also, effects of long term covid 19 have made adverse effects worse with increase in severe dizziness (head trauma and elevated blood pressure from chronic pain), been on going now for over 18 months
This spontaneous report as received from a physician refers to a multiple patients of unknown ages and genders. Pertinent medical history, concurrent conditions and drug reactions or allergies were not reported. On an unknown dates the patients were vaccinated with improperly stored GARDASIL 9 lot # M003659, expiration date 20-SEPT-2017, (Dose, route and anatomical location were not provided). Other suspect product involved was sterile diluent (MERCK sterile diluent) lot # L041683 Expiration date 19-MAY-2018 and Lot # M002421 Expiration date 22-JUL-2018. Temperature: Lowest 25 Fahrenheit degrees (4 cycles) below. Time frame: 1 week. Previous: No. Digital data logger was involved. No product quality complain was involved. No other concomitant medication was reported. This is one of five reports received from the same reporter. Additional information has been requested.
3-22-10 client called - states spiked fever evening of 3-16-10 of 102.3. Left arm became very sore and swollen from elbow to shoulder. Saw pp. Sat 3-20-10 - diagnosed as cellulitis and put on KEFLEX x 10 days. Swelling decreased - states feeling better - still running a low grade fever. 3-24-10 hospitalized x2 days with IV antibiotics.
Patient had received the nasal spray around 12pm.  He had decreased energy and fell asleep in the car that afternoon (doesn't usually do that).  He had decreased appetite and complained of stomach pains that evening around 8:30pm.  He starting vomiting around 11:45pm and vomited 4-5 times throughout the night.  I gave patient some phenergan liquid.  He also complained of a headache. Patient stopped vomiting and was able to hold down liquids the next morning.
Case number PHEH2016US026284, is an initial spontaneous report received from a nurse on 07 Oct 2016. This report refers to a patient of an unknown age and an unknown gender. Past medical history and concomitant medications were not reported. The patient was vaccinated with single dose of FLUCELVAX (unknown whether seasonal or pandemic, manufacturer and batch number: not reported) at a dose of 0.5 ml, intramuscularly on an unknown date. It was reported that, one of the physician patient, that was administered a FLUCELVAX shot and they had an adverse reaction. On an unknown date, the patient became itchy and looked like they had hives from the shot. The outcome of the events was reported as unknown. Seriousness and causality of the events were not reported.
This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient. A 69-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Oct2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 68 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 13Jun2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 25Jan2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 22Feb2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 02Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "endometrial cancer in remission" (unspecified if ongoing), notes: endometrial cancer in remission. The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 13Jun2022, outcome "unknown", described as "dose #1: Moderna/ dose #2: Moderna / dose #3: Moderna / dose #4 Pfizer / dose #5 Pfizer"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient had no known allergies. Patient took Paxlovid from 13Dec2022 to 18Dec2022 for Covid-19 treatment.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events and BNT162B2.
2nd one a lot more fatigued; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient received BNT162b2 (BNT162B2), on 09Apr2021 as dose 2, single (Lot number: EW0153) at the age of 67 years for covid-19 immunisation. The patient's relevant medical history included: "Osteoporosis" (ongoing), notes: diagnosed 7 years ago.; "Arthritis" (unspecified if ongoing); "left branch bundle blockage" (unspecified if ongoing), notes: L branch bundle blockage had all her life. takes no medication for this and there is no treatment; "Asthma" (ongoing), notes: she developed asthma. Concomitant medication(s) included: ALBUTEROL [SALBUTAMOL] taken for asthma (ongoing); PROLIA subcutaneous taken for osteoporosis. Vaccination history included: BNT162b2 (1st one she felt a little foggy and maybe just a little tired), administration date: 19Mar2021, when the patient was 67-year-old, for COVID-19 Immunization, reaction(s): "little tired", "felt a little foggy". The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "2nd one a lot more fatigued". Relevant laboratory tests and procedures are available in the appropriate section.   Additional information : Covid vaccine: 1st one she had was Oct2021. Clarified she thought first one was 19Mar2021. She had 3 in 2021. March, April and October. All were Pfizer Covid vaccines. 1st one she felt a little foggy and maybe just a little tired. 2nd one a lot more fatigued. 3rd one in October was very similar to 1st one. Then had more, the 4th in Apr2022. Nothing remarkable about it. A little fatigued and a little soreness at site. Then had another one in May2023 and doesn't recall feeling anything but fatigue. Just felt kinda wiped out and tired.
Three days after receiving COVID vaccine, I got my period and I had no had it in ten months due to menopause.
Received measles vaccine 09/17/2001. Noted flin like sxs one week later. Two weeks after vaccine developed low grade fever. Currently has maculopupular rash on face, neck and forearms.
Pain, swelling, redness, warmth. Started evening of injection. Used ice pack for treatment.
This spontaneous case reported by a consumer, describes the occurrence of pain, aches and headache in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 027A21A) for COVID-19 immunization. The patient's past medical history included splenectomy. Concurrent medical conditions included immunocompromised (she is immunocompromised since she had her spleen removed). Concomitant product: clonazepam taken half of a 2.5 mg at night for sleep problem. On Mar 10, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 10, 2021, patient experienced pain, aches and headache. Patient treated with Tylenol (paracetamol) for adverse event, at an unspecified dose and frequency. On Mar 12, 2021, pain, aches and headache resolved. The reporter did not provide any causality assessments or treatment information. This case linked to MOD-2021-295323 (patient link).
I started to have palpitations and was diagnosed with premature ventricular contractions and placed on a heart monitor for 48 hours which showed 20% of contractions as PVC. I had a stress test that was negative also. I took OTC magnesium which brought the symptoms down significantly.
pt recv vax;w/in 2 hr leg very red w/5x3cm erythema; hot but not hard;screamed,high pitched scream when touched or moved;to er;cool packs & ped ibuprofen recommended;still red,tender area as of 26apr;seems ok now;
At first, I had chills and fever that lasted a day or so. Then, I lost my taste and smell. I also been coughing which as well started Sunday. I had nausea and diarrhea. I went to an urgent care clinic. They did a COVID-19 test, came back positive.
Patient, 2/22/1950, received a Fluzone HD vaccine at our pharmacy 10/18/20 at 12:04 pm.  Patient's wife called at 4:05 pm and stated that the patient was experiencing blurred vision and chest tightness/lump in his throat.  I immediately suggested that they call their PCP or go to an urgent care center in case it is an allergic reaction.  She asked if Benadryl was ok to give him. I stated that Benadryl would help if it's an allergic reaction but since he's having a lump feeling in his throat he may need something stronger.  The wife asked if this was common after the vaccine.  I checked facts and comparisons to see if there was information on this and explained to her that there is an oculorespiratory syndrome documented that begins within 2-24 hours after vaccine administration.  I told her that it stated that it was an acute self-limiting reaction that usually resolves within 48 hours and the symptoms include chest tightness, cough, wheezing, difficulty breathing, facial swelling, red eyes and sore throat.  I told her that even though it says it is self-limiting, I would still recommend they call their PCP or go to the urgent care to verify it isn't an allergic reaction or something else.  I also told her that I would document the reaction in his profile.
Patient came to receive updated Tdap. Patient called an hour later to describe a few bumps that were itching on arm and chest area. No other s/s described. Patient stated that he took 50 mg of Benadryl. Patient recommended to contact PCP for further follow up.
anaphylactic reaction; This is a spontaneous report from a contactable consumer or other non hcp (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number: not reported) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient was a mother who was calling regarding her child. On an unspecified date, she stated regarding herself that she had an anaphylactic reaction with the first dose of the Pfizer COVID19 vaccine and so we would not be getting the second dose. She would like to know if any data on how likely her child was to have the same type of reaction. She stated that she would like to know a certain percentage of people who have had an anaphylactic reaction. She had spoken to 3 doctors and they did not know how likely it would be for her child to have the same reaction. The clinical outcome of the event was unknown at the time of report.  Information on the lot/batch number has been requested.
Pt. states after receiving Moderna 1st dose 06/28/2021 started experiencing HBP, wheezing, 170/30 BP, fever. Chills, anxiety attack, headaches, nauseous, fatigue, high heart rate, Primary will not see pt. without being fully vaccinated.
not been feeling well; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not been feeling well) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 12-May-2021 at 2:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (not been feeling well). At the time of the report, MALAISE (not been feeling well) outcome was unknown.            No concomitant medication details provided.  No Treatment medication details provided.  The reporter reported that the patient have not been feeling well after her second vaccine. she would log in later if she felt better. she will also report her symptoms to the Moderna PV team according to the fact sheet since is the vaccine she received.
Client felt nauseas and vomited x1. Client was laid down and feet placed up. Client recovered and left with mother without any assistance. Client a former 34 wk premie, with history of chicken pox and pneumonia after discharged from hospital.
passed out in car. felt weak and fell over (according to spouse) syncope. Evaluated by EMS- Transported to Emergency room/department or urgent care.
Soreness for 48hrs at vaccination site; This is a spontaneous report received from a contactable nurse (patient). A 37-year-old female non pregnant patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, Lot number: EL3247), via an unspecified route of administration on left arm on 04Feb2021 12:30 at single dose for COVID-19 immunisation at workplace clinic. The patient medical history included known allergies with Sulfa drugs and Dust mites. The patient concomitant medications included daily multivitamin (unspecified) received within two weeks of vaccination. The patient was not received other vaccine in four weeks. On 04Feb2021 18:00, the patient experienced soreness for 48hrs at vaccination site. No treatment was received for the event. The patient not had COVID prior vaccination. The patient not tested for COVID post vaccination. The outcome of the event was recovered on an unspecified date in 2021.
Patient reported to pharmacy on October 3rd that since receiving the vaccination on September 20th 2017 her arm had been sore and any time she tried to lift the arm, she always experienced severe pain.
a dark bruise on her chin / she found a bruise on her chin that was sore and tender; This is a spontaneous report from a contactable consumer (patient herself). A 80-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection Batch/Lot number: EL9263, Expiration Date was not reported), via an unspecified route of administration on 29Jan2021 16:00 (at the age of 80-year-old) as 1st dose, single for covid-19 immunisation. Medical history was not reported. Concomitant medication included acetylsalicylic acid (BABY ASPIRIN, 81 mg once daily by mouth). Additional Information for Concomitant Products Baby Aspirin is- It is just preventative. She is not prescribed it, she just takes it. On 29Jan2021, patient states that noticed later that evening she had a dark bruise on her chin. patient does not remember hitting anything or running into anything that would have caused this bruise to form on her chin and she is asking if this could be a potential side effect of the vaccine. She denies any swelling of the face, throat or mouth. She denies any difficulty breathing. patient states, if you saw my face you would think I've been in a fight" and it was exacerbated but it is quite black and blue, she knows it takes time to go down. Patient noticed the bruise later the same day and it is still tender like underneath your chin towards the gland, it is fading but it is still blue. It is just a tad fading, starting to fade. She says she also takes a minor dose of a blood pressure medication that she cuts in half actually but she is not sure if there maybe properties of that with something in the vaccine that might have done it. No further information provided. The outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
Headache, aches, chills, shortness of breath, fatigue.  Felt worse than all, but 2 days that I actually had COVID back in December for 17 days.
This spontaneous case, was initially received from other health professional (nurse) on 03-Oct-2017, concerning a 30-year-old adult female patient. The patient's historical vaccine included unspecified influenza vaccine without any reaction. The patient's concomitant medications were not reported. On 29-Sep-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, batch number: 195126, expiry date: 30-Apr-2018, route of administration and anatomical location: not reported). It was reported that, within 24 hours of vaccination, the patient had symptoms of localized redness, swelling and heat at the site of minor intensity, which lasted for 3 days. No treatment was given for the events. At the time of this report, the outcome of the events was recovered. The reporter assessed the report as non-serious. Non-significant case correction received 03-Oct-2017: Batch number (195126) was captured in the case form and narrative was amended accordingly.
Patient received the high dose flu shot around 1:30PM. Patient reports the onset of nausea around 4:30PM which led to vomiting around 5-5:30PM. She continued to have nausea and vomiting for about 24 hours. Also had a fever of about 101 during this time. Patient had bouts of chills and shakiness throughout this period. Complains of headache and body aches for an unspecified time afterwards. Patient has not previously had issues with the flu shot but this is the first instance of her getting the high dose version.
Patient was seen at COVID Vaccine Clinic today for her first dose of the COVID 19 vaccination.  She denied any history of previous adverse reactions to vaccines. She reports that she also had a shingles and pneumonia vaccination on Monday 12/14/2020. She confirmed with both her PCP and transplant specialist that okay to receive all vaccinations.    She was given the Pfizer vaccination in the right deltoid muscle.   During her 15 minute waiting period after the injection, the patient began to experience tongue tingling and swelling specific to the left side of her tongue.  She denied rash, difficulty breathing, difficulty swallowing, wheezing, throat tightness, dizziness and lip swelling.  She reports similar reactions after receiving other vaccinations. States that those symptoms always resolved with time and never required any treatment.    This APP was notified of patient reaction and she was then assessed in the emergency bay area.   Vitals Vitals:   12/17/20 1545 12/17/20 1555 12/17/20 1620 BP: 128/85 116/72 126/73 BP Location: Left arm Left arm Left arm Patient Position: Sitting Sitting Sitting Pulse: (!) 109 100 99 Resp: 12 12 12 SpO2: 99% 97% 98%   Physical Exam  Constitutional: She is oriented to person, place, and time. She appears well-developed and well-nourished. No distress.  HENT:  Nose: Nose normal.  Mouth/Throat: Oropharynx is clear and moist.  Neck: No tracheal deviation present.  Cardiovascular: Normal rate, regular rhythm and normal heart sounds.  Pulmonary/Chest: Effort normal and breath sounds normal. No stridor. No respiratory distress. She has no wheezes. She has no rales.  Musculoskeletal:        General: No edema.  Neurological: She is alert and oriented to person, place, and time.  Skin: Skin is warm and dry. No rash noted. She is not diaphoretic. No erythema.  Psychiatric: She has a normal mood and affect. Her behavior is normal. Thought content normal.    Patient's health history, medications and allergies were reviewed. She denied any further symptoms and the tongue numbness/swelling resolved in 30 minutes. She specifically denied any difficulty swallowing or breathing. No treatment was required. Pharmacy responded and did advise that current recommendations include no other vaccinations within two weeks of COVID. Discussed with patient. She is advised to notify staff of this reaction when receiving her 2nd dose. Patient release after 45 minutes of observation.
I just woke up and I was completely sweaty. This was the morning after my vaccination. I had my son here and he thought I was going to have a seizure. It was almost like the chills, it would not stop. I was nauseas, I was achy and so sore. I took Tylenol and kept putting cool clothes on my body as best I could. This lasted for about 4 days, I was in bed for those four days. Extreme fatigue. And when I saw very sweaty, my son had to change my sheets for me because they were so wet. A few weeks after that I got extreme pain in my abdomen and I had to have my appendix removed. At that time I was informed that I had the beginning of kidney stones. We have not addressed them because I have had one problem after the next. I did not contact my doctor during that time but did see them afterwards. I was aware of the side effects and figured that was it. I had no energy, no appetite or anything. I did get sick vomiting for four days as well. I still have sore joints, but not as bad. I am trying to cut back on carbohydrates to cut back on inflammation. I handle pain very well usually. My daughter wanted me to go to the hospital. I went to the DR for appendicitis and I ended up very sick from all the antibiotics as well.
First dose: sore arm.  Second dose: severe chills, headaches, nausea, hallucinations lasting almost 28-36 hours.  Tylenol helped, but switched to Excedrin for better results.  Queasiness remains after 36 hours, but better.
Pt got first two doses of Moderna on March 19th and April 16th. Came to get her third dose because she was immunocompromised, we gave her Pfizer. Since this was third dose, it should have been Moderna as part of the first series.
pt recv vax 24NOV97 & w/in 10min of receiving vax pt exp numbness in hands & in back, tingling in fingers & nausea;
a little heat at the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. A 78-year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as 2nd dose, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE WARMTH (non-serious), outcome "unknown", described as "a little heat at the injection site". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I experienced several side effects beginning Sunday at 2:00 p.m.  I was lethargic and could barely keep my eyes open for most of the day on Sunday.  My entire body ached.  I went to bed early and slept for 11 hours.  On Monday, I went to work, but was achy and tired the entire day and half way through the day experienced nausea and vomited (I have not vomited in 20 years).  Tuesday and Wednesday I was still tired and achy.   My left arm was sore for the entirety of the week and on Wednesday it was tingly (like it was asleep) from my shoulder to my finger tips. For four days, Sunday-Wednesday, I experienced a low, dull headache.  I was taking Advil and Tylenol  (interchanging) for the better part of all four days.  In addition, I was drinking water as suggested.